Victoria Hale

"Dr. Victoria Hale, a pharmaceutical scientist and global health social entrepreneur, is the Founder of Medicines360...r. Hale is Founder and Chair Emeritus of OneWorld Health, the first nonprofit pharmaceutical company in the United States. She founded the company in 2000 and served as its first Chairman and CEO from 2000 to 2008. Under Dr. Hale’s leadership, OneWorld Health developed a new cure for visceral leishmaniasis, launched a novel approach to treat dehydrating diarrhea, and developed a platform technology to reduce the cost of malaria drugs more than tenfold. Dr. Hale established her expertise in all stages of biopharmaceutical drug development at the U.S. Food and Drug Administration and at Genentech. She earned her PhD in Pharmaceutical Chemistry from University of California San Francisco, where she presently maintains an Adjunct Associate Professorship in Biopharmaceutical Sciences.

"Dr. Hale was granted the MacArthur “Genius” Award 2006 and was elected to membership in the Institute of Medicine of the U.S. National Academy of Sciences in 2007. She has received the President’s Award of Distinction from the American Association of Pharmaceutical Scientists. In 2005, the Economist named Dr. Hale the recipient of its Social and Economic Innovation Award. She has been recognized internationally as a senior social entrepreneur by the Skoll Foundation, Schwab Foundation, and Ashoka."

"Dr. Hale is a pharmaceutical scientist/executive and global health social entrepreneur. She currently has a consulting business focused on global health and integrative medicine. She was founder and CEO of two successful nonprofit pharmaceutical companies, OneWorld Health (2000) and Medicines360 (2009). OneWorld Health was the first nonprofit pharmaceutical company in the U.S., focused on leishmaniasis, malaria, and cholera; Meds360 developed a hormonal IUD for contraception, approved by the FDA. She has raised $230M in philanthropic funding, primarily from the Bill & Melinda Gates Foundation. She has partnered with multiple global pharmaceutical companies for the discovery, manufacturing, and commercialization of global health products. "

• Chair, Multidisciplinary Association for Psychedelic Studies